Abstract:Background: One of the most common cancers worldwide is hepatocellular carcinoma (HCC). Studies have shown that Hepatitis B virus (HBV) X gene (HBx) mutations play a potentially important oncogenic role in the pathogenesis of this disease. However, the molecular mechanisms underlying the malignant transformation of liver cells following HBV infection are poorly understood. We previously identified a novel deletion mutation in HBx (HBx-d382) that is capable of transforming hepatocytes and increasing their tumorigenic capacity. As part of the afore-mentioned study, we also identified reverse transcriptase enzyme (rt)/s* double mutants in nucleoside analogue (NA)-resistant patients. This current study was conducted to determine if HBx-d382 and rt/s* mutations co-exist in HCC patients. The study also aimed to identify the role of these mutations in HCC. Methods: DNA from serum samples obtained from 152 NA-resistant patients with chronic hepatitis B (CHB) and 33 patients with HCC were sequenced to identify samples harboring both the HBx-d382 mutation and rt/s* double mutations. As part of this study, we also generated lentivirus constructs carrying different HBV mutations including rtA181T/sW172*, rtM204I/sW196*, HBx-d382, rtA181T/sW172*/HBx-d382 and rtM204I/sW196*/HBx-d382. The recombinant viral constructs were used to infect a human hepatocyte cell line (LO2). The LO2 cell line was used to evaluate the effect of the mutations on apoptosis, cellular proliferation and the rate of colony formation in the LO2 cells harboring different mutations. Results: We identified rt/s*/HBx-d382 mutations in both HBV-related HCC and NA-resistant CHB clinical samples and observed that the rate of occurrence of rt/s*/HBx-d382 mutations in HBV-related HCC is relatively high. The results of this study revealed that the rtA181T/sW172* and rtM204I/sW196* double mutants exhibited enhanced proliferation, reduced apoptosis and an increased rate of colony formation in LO2 cells. Expression of p53 and CyclinD1 were increased and the level of p21 was decreased in the rtA181T/sW172* and rtM204I/sW196* expressing LO2 cells. More importantly, rt/s* double mutations combined with the HBx-d382 mutation resulted in more severe phenotypes compared with rt/s* double mutation alone in LO2 cell lines. Conclusions: Our data suggest that rt/s*/HBx-d382 triple mutants play a crucial role in HBV-mediated HCC formation.

[Role of the Liver-Enriched Transcription Factor Binding Site Mutation in the C Promoter Region of Hepatitis B Virus Genome for HBx-enhanced Hepatitis B Virus Replication].

[On the Role of Liver-Enriched Transcription Factors in Regulating HBV Transcription and Replication].

HBV C Promoter Sp1 Binding Sequence Functionally Substitutes for the Yeast ARS1 ABF1 Binding Site

The regulatory role of liver-enriched transcription factors in HBV gene transcription and replication

The Transcriptional Transactivation Function of HBx Protein is Important for Its Augmentation Role in Hepatitis B Virus Replication

Role and functional domain of hepatitis B virus X protein in regulating HBV transcription and replication in vitro and in vivo.

Regulatory Effect of HBV Integrated Fragment on PCNA Promoter.

Transcription and Replication of a Natural Hepatitis B Virus Nucleocapsid Promoter Variant Is Regulated in Vivo by Peroxisome Proliferators

The A1762T/G1764A Mutations Enhance HBV Replication by Alternating Viral Transcriptome.

HBx Deletion-Mutant Combined with the Reverse Transcriptase Enzyme/s* Mutation is Involved in HBV Mediated Liver Cell Proliferation and Apoptosis

Effect of hepatitis B virus whole-X gene on HEK293 cells

Hepatitis B Virus X Protein Modulates Remodelling of Minichromosomes Related to Hepatitis B Virus Replication in HepG2 Cells

A Mutant of HBx （hbxδ127） Promotes Hepatoma Cell Growth Via Sterol Regulatory Element Binding Protein 1c Involving 5-Lipoxygenase

[Mechanism and Clinical Significance of HBx-mediated Inhibition of CYP2E1 Expression in the Human HepG2 Hepatoma Cell Line].

Comparison of hepatitis B X gene mutation between patients with hepatocellular carcinoma and patients with chronic hepatitis B

Functional Characterization of Hepatitis B Virus Core Promoter Mutants Revealed Transcriptional Interference among Co-Terminal Viral Mrnas.

Regulation of hepatitis B virus transcription and replication by liver-enriched transcriptional factors

Hepatocellular carcinoma cells containing hepatitis B virus X protein have enhanced invasive potential conditionally.

Impact Of Hepatitis B Virus Basic Core Promoter Mutations On T Cell Response To An Immunodominant Hbx-Derived Epitope

The G1613A Mutation in the HBV Genome Affects HBeAg Expression and Viral Replication through Altered Core Promoter Activity

Analysis of hepatitis B virus X gene (HBx) mutants in tissues of patients suffered from hepatocellular carcinoma in China.